Clinical Trial Update: Observational Study of Efficiency of Cytoflavin, in Patients With Ischemic Stroke Not Receiving Reperfusion Therapy

View source ↗

Summary

An observational clinical study is evaluating the effectiveness of Cytoflavin in patients with acute ischemic stroke who are not receiving reperfusion therapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Cytoflavin

Snippet

Sponsor: POLYSAN Scientific & Technological Pharmaceutical Company | Conditions: Stroke, Acute, Stroke, Ischemic | Status: RECRUITING